Switch View
© ACCESSWIRE
13.11.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
News Preview
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / November 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advan...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: FR0010331421
Innate Pharma SA
IPH
LISTED
EURONEXT
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
News Preview
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced its business update and financial results for the first nine months of 2025.
“This quarter highlights strong execution across our key programs,” said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “With FDA clearance...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals
News Preview
Regulated information November 13, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
13.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis Prices Convertible Notes Offering to Refinance 2026 Convertible Notes
News Preview
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the pricing of $700.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2030 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Ionis also...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
13.11.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon veröffentlicht Neunmonatsergebnis und bestätigt Prognose – Pipeline-Fortschritte und starke Partnerschaften prägen Geschäftsjahr 2025
News Preview
Pressemitteilung // 13. November 2025
Formycon veröffentlicht Neunmonatsergebnis und bestätigt Prognose – Pipeline-Fortschritte und starke Partnerschaften prägen Geschäftsjahr 2025
Prognose für 2025 bestätigt – Umsatz- und Ergebnisentwicklung im Rahmen der Erwartungen
FYB202 (Stelara®1-Biosimilar): Markterschließung in den USA und Europa schrei......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.11.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
News Preview
Press Release // November 13, 2025
Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
Guidance for 2025 confirmed – Revenue and earnings development in line with expectations
FYB202 (Stelara®1 biosimilar): Market penetration in the US and Europe continues
Significant ......
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
News Preview
Company announcement – No. 23 / 2025...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
ROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the "Class Period") of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you pur...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US03589W1027
Annexon Inc
ANNX
LISTED
NASDAQ
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
News Preview
BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the pricing of its previously announced underwritten public of...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON PERRIGO COMPANY PLC (PRGO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.SO WHAT: If you pu...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.SO WHAT: If y...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
13.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR DEADLINE ALERT: ROSEN, A LONGSTANDING FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Law Offices of Howard G. Smith Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2025 to file a lead plaintiff...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their OptionsIf you suffered losses in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly a...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US1710774076
Niagen Bioscience Inc
CDXC
LISTED
NASDAQ
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
News Preview
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind clinical trial published today in The Lancet peer-reviewed journal eClinicalMedicine demonstrating that daily supplementation with Niagen®,...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their OptionsIf you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US14216J1097
Caring Brands, Inc.
CABR
LISTED
NASDAQ
Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq
News Preview
FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the pricing of its underwritten U.S. public offering of 1,000,000 common shares at a public offering price of $4.0...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit ha...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US50015M1099
Kodiak Sciences Inc
KOD
LISTED
NASDAQ
Kodiak Sciences to Present at Upcoming Investor Conferences
News Preview
PALO ALTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, M.D., Chief Executive Officer, will present at the f...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Nov. 12, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US2274831047
Cross Country Healthcare Inc
CCRN
LISTED
NASDAQ
Cross Country Healthcare Announces Third Quarter 2025 Financial Results
News Preview
Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025.
Selected Financial Information:
Variance
Variance
Q3 2025 vs
Q3 2025 vs
Dollars are in thousands, except per share amounts
Q3...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US03675P1021
Anteris Technologies Global Corp.
AVR
LISTED
NASDAQ
Anteris Announces Results for the Third Quarter of 2025
News Preview
Anteris Technologies (NASDAQ: AVR, ASX: AVR) reports financial results for the quarter ended September 30, 2025, and provides a corporate update....
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avantor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jos...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=177026&wire=5&...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Securities Lawsuit Alert: aTyr Pharma, Inc. (ATYR) Investors - Contact Levi & Korsinsky Before December 8, 2025
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ: ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=177024&wire=5&ut...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Far...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP INVESTOR ALERT: Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
San Diego, California--(Newsfile Corp. - November 12, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek appointment as lead plaintiff of...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction and acute ischemic stroke (AIS), today provided a business update and reported financial results for the third quarter ended September 30, 2025. Management will host a confere...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: CA76134J2065
Restart Life Sciences Corp
HEAL
LISTED
CSE
Restart Life Sciences Announces Private Placement Financing
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a non-brokered private placement of up to 10,000,000 units in the capital of the Company (each, a "Unit") at a price of CAD $0.10 per Unit for aggregate gr...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, LEADING TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US42227G2021
HealthWarehouse.com, Inc.
HEWA
LISTED
OTC
HealthWarehouse.com Reports Results for Third Quarter 2025
News Preview
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the third quarter ended September 30, 2025, totaled $8.4 million, a 7% decrease from the quarter ended September 30, 2024. The Company reported a net loss of $72,000 and Adjusted EBITDA of $343,000 for the quarter. Year to date, the Company reported sales of $39.1 millio...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US80706P1030
Scholar Rock Holding Corp
SRRK
LISTED
NASDAQ
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 30,000 shares of its common stock to 1 newly hired employee, consisting of inducement stock options to purchase an aggregate of 17,143 shares of common stock and inducement restricted stock units, covering an aggreg...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US29337E1029
Enliven Therapeutics Inc
ELVN
LISTED
NASDAQ
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
News Preview
Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML
Remains on track to initiate Phase 3 pivotal trial of ELVN-001 in 2026
Strong balance sheet with $478 milli...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US00444T2096
Talphera Inc
TLPH
LISTED
NASDAQ
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.
Cash and investments at September 30, 2025 were $21.3 million; combined with conditional future tranches of previous financings, expect sufficient cash through a potent...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US1143401024
Azenta Inc
AZTA
LISTED
NASDAQ
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
News Preview
BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens.
The Company will host a conference call and live webcast to discuss...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
News Preview
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US90240B1061
Tyra Biosciences Inc
TYRA
LISTED
NASDAQ
Tyra Biosciences Announces Participation at Upcoming Investor Events
News Preview
CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company manag...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US2854091087
Electromed, Inc.
ELMD
LISTED
XASE
Electromed, Inc. Announces First Quarter Fiscal 2026 Results
News Preview
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 (“Q1 FY 2026”).
Q1 FY 2026 Company Highlights
Net revenues increased 15.1% to $16.9 million in Q1 FY 2026, from $14.7 million in the first quarter of the p...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025.
“Our recent strategic financings further strengthen our balance sheet, significantly increase our cash runway, and allow us to accelerate our invest...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US7599101026
KORU Medical Systems Inc
KRMD
LISTED
NASDAQ
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
News Preview
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025.
Recent High...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
agilon health to Participate in the 8th Annual Evercore Healthcare Conference
News Preview
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 3:00pm ET.
Interested investors and other parties may listen to a sim...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US22053A1079
Quince Therapeutics Inc
CRTX
LISTED
NASDAQ
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on the company’s development pipeline and reported financial results for the third quarter ended September 30, 2025.
Dirk Thye, M.D., Quince’s Chief...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US88338N2062
TherapeuticsMD Inc
TXMD
LISTED
NASDAQ
TherapeuticsMD Announces Third Quarter 2025 Financial Results
News Preview
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2025.
Third Quarter 2025 Financial Results
Net Income (Loss) from Continuing Operations
Net income from continuing operations was $50 thous...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
GRAIL Reports Third Quarter 2025 Financial Results
News Preview
Q3 U.S. Galleri Revenue Grew
28%
Year-Over-Year to
$32.6 Million
Q3 Galleri Tests Sold Grew 39% Year-Ove...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat immune-mediated diseases, today reported financial results for the third quarter ended September 30, 2025.
In October, Kezar announced that it has been unable to align with the Food and Drug Administration (FDA) o...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US0373261058
AN2 Therapeutics Inc
ANTX
LISTED
NASDAQ
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
News Preview
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the third quarter ended September 30, 2025.
“This quarter, we continued to execute across a diverse pipeline spanning multiple,...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced positive, updated interim clinical data in the pediatric cohort (ages 4-10 cohort) from its ongoing Phase 1/2 trial evaluating NGN-401 gene therapy for the treatme...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
News Preview
Cytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026....
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to present at upcoming investor conferences
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
Stifel 2025 Healthcare Conference on Thursday, November 13, 2025
Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
A live webcast of these presentations can be accessed on...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
News Preview
REYKJAVIK, Iceland, November 12, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary of recent pipeline and corporate highlights. Management...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
News Preview
REYKJAVIK, Iceland, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary of recent pipeline and corporate highli...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: CA72706K1012
Planet 13 Holdings Inc.
PLTH
LISTED
CSE
Planet 13 Announces Q3 2025 Financial Results
News Preview
All figures are reported in United States dollars ($) unless otherwise indicated...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
